Protecting Americans from Unsafe Drugs Act of 2026
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsor
- 1
- Latest action
- Mar 18, 2026
What it does
The Protecting Americans from Unsafe Drugs Act of 2026 would amend the Federal Food, Drug, and Cosmetic Act to expand the FDA’s authority to order the cessation of distribution and recall of drugs—previously limited to controlled substances—to apply to all drugs. It would also update import and export provisions to align with this broader authority, ensuring that any drug subject to an FDA recall order cannot be imported or exported. The bill affects drug manufacturers, distributors, importers, exporters, and the FDA, enhancing the agency’s ability to swiftly remove unsafe drugs from the market regardless of their classification as controlled substances.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.